Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients

V. Coviello, F. Peluso, S.Z. Dehkhargani, F. Verdugo, L. Raffaelli, P.F. Manicone

Article ID: 6112
Vol 26, Issue 1, 2012
DOI: https://doi.org/10.54517/jbrha6112
Received: 8 April 2012; Accepted: 8 April 2012; Available online: 8 April 2012; Issue release: 8 April 2012

Abstract

Bisphosphonates are drugs used to treat various metabolic and malignant bone diseases. In the past 10 years intravenous bisphosphonates have been associated with increased risk of osteonecrosis of the jaw (ONJ). The aim of the present study is to evaluate platelet-rich plasma (PRP) wound healing benefits in multiple myeloma (MM) patients who developed ONJ after surgical tooth extraction. The study included 7 patients, 2 males and 5 females. All individuals had been taking zoledronate or pamidronate followed by zoledronate for an average of 5 years. Four subjects had only standard surgical debridement and sequestrectomy to treat the ONJ and three had additional autologous PRP. The patients were followed-up for 3 months. The use of PRP to enhance wound healing and reduce bone exposure seems to be a good treatment protocol in ONJ MM subjects


Keywords

bisphosphonates;osteonecrosis of the jaw;multiple myeloma;platelet-rich plasma


References

Supporting Agencies



Copyright (c) 2012




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).